Terms

FormularySignal Terms

Effective date: April 25, 2026. FormularySignal is an automated public-data monitoring service for FDA/openFDA drug shortage watchlists. The service is not medical advice, not legal advice, not inventory advice, not clinical decision support, not procurement advice, and has no FDA affiliation or endorsement.

Operator: FormularySignal. Contact: support@formularysignal.com. No professional review is claimed. The service is offered as a low-claims public-data service, and users are responsible for verifying official source records before relying on any output.

Service Scope

FormularySignal monitors public FDA/openFDA drug shortage records, stores public-data snapshots, identifies visible changes, and delivers watchlist-specific summaries by configured channels. It does not provide real-time inventory, supplier availability, purchasing instructions, clinical substitutions, dosing, prescribing guidance, or permission to compound, purchase, sell, or distribute any drug product.

Subscriptions and Billing

Paid plans are monthly subscriptions that renew until canceled. Stripe processes payments; FormularySignal does not store card numbers. Prices shown before checkout do not include taxes unless stated otherwise. Billing portal access requires a one-time email verification link or a recent Stripe checkout session.

Cancellation and Refunds

Customers may request cancellation through support or through the customer billing portal when production billing is enabled. Refunds are available for duplicate or mistaken charges. Delivered subscription periods are not prorated except where required by law or agreed in writing.

Acceptable Use

You may use the service for source-query public-data monitoring and research. You may not use it to automate hoarding, purchasing, resale, price manipulation, panic marketing, patient targeting, supplier brokering, or unlawful drug sales.

No Patient Data

Do not submit protected health information, patient names, medical record numbers, prescription-level details, dates of birth, addresses, or patient-specific treatment context. If you believe PHI was submitted accidentally, contact support promptly so the data can be reviewed and deleted from operational systems where feasible.

Source Data

Source records come from public FDA/openFDA drug shortage data. Public records may contain delays, omissions, corrections, changed classifications, or API availability issues. Always verify important records against the official source. Do not use FormularySignal as the basis for clinical, legal, purchasing, inventory, compounding, sourcing, patient, or emergency decisions.

Availability and Liability

The service is provided as-is. Reports can be delayed, incomplete, incorrect, or unavailable because of source-data availability, network failures, payment status, email delivery issues, maintenance, bugs, or processing errors.

No FDA Affiliation

FormularySignal is not affiliated with, endorsed by, sponsored by, or approved by the U.S. Food and Drug Administration.